National Cancer Institute; Notice of Meeting, 62477 [06-8883]
Download as PDF
Federal Register / Vol. 71, No. 206 / Wednesday, October 25, 2006 / Notices
Dated: October 18, 2006.
Suzanne Freeman,
NHLBI Project Clearance Liaison, National
Institutes of Health.
Dated: September 26, 2006.
Peter Savage,
Acting Director, DPPS, National Institutes of
Health.
[FR Doc. E6–17898 Filed 10–24–06; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
mstockstill on PROD1PC61 with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Director’s Council of Public
Representatives.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Director’s Council of
Public Representatives.
Date: November 3, 2006.
Time: 8:30 a.m. to 5 p.m.
Agenda: Among the topics proposed for
discussion are: (1) NIH Director’s update: (2)
Discussion on the Role of the Public in the
Research Process; (3) Genome-Wide
Association Studies Briefing; (4) NIH
Foundation Activities Report; (5) Update on
Biomarkers of Disease; (6) NIH
Communications Update; and (6) discussion
and public comment.
Place: National Institutes of Health,
Building 31, Conference Room 6, 9000
Rockville Pike, Bethesda, MD 20892.
Contact Person: Jennifer E. Gorman, NIH
Public Liaison/COPR Coordinator, Office of
Communications and Public Liaison, Office
of the Director, National Institutes of Health,
9000 Rockville Pike, Building 31, Room
5B64, Bethesda, MD 20892, (301) 435–4448,
gormanj@od.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel and airport shuffles
will be inspected before being allowed on
VerDate Aug<31>2005
15:12 Oct 24, 2006
Jkt 211001
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state he purpose of their
visit. Information is also available on the
Institute’s/Center’s home page https://
www.copr.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: October 17, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8882 Filed 10–24–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given on the meeting of the
President’s Cancel Panel.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(9)(B), Title 5 U.S.C., as
amended, because the premature
disclosure of information and the
discussions would likely to significantly
frustrate implementation of
recommendations.
Name of Committee: President’s Cancer
Panel.
Date: December 5, 2006.
Open: December 5, 2006, 8 a.m.–4 p.m.
Agenda: Promoting Healthy Lifestyles to
Reduce the Risk of Cancer.
Place: Oregon Health & Science University
Cancer Institute, 3181 Southwest Sam
Jackson Park Road, Portland, OR 97239.
Closed: December 5, 2006, 4 p.m.–8 p.m.
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
62477
Agenda: The Panel will discuss the
Promoting Healthy Lifestyles to Reduce the
Risk of Cancer and discuss potential topics
for the 2007/2008 series.
Place: Oregon Health & Science University
Cancer Institute, 3181 Southwest Sam
Jackson Park Road, Portland, OR 97239.
Contact Person: Abby Sandler, PhD,
Executive Secretary, National Center
Institute, National Institutes of Health,
Building 6116, Room 212, 6116 Executive
Boulevard, Bethesda, MD 20892, 301/451–
9399.
Any interested person may file written
comments with the committee by forwarding
the comments to the Contact Person listed on
this notice. The comments should include
the name, address, telephone number and,
when applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
deainfo.nci.nih.gov/advisory/pcp/pcp.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: October 17, 2006.
Linda Payne,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8883 Filed 10–24–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel,
E:\FR\FM\25OCN1.SGM
25OCN1
Agencies
[Federal Register Volume 71, Number 206 (Wednesday, October 25, 2006)]
[Notices]
[Page 62477]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-8883]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given on the meeting of
the President's Cancel Panel.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in section 552b(c)(9)(B), Title 5 U.S.C., as
amended, because the premature disclosure of information and the
discussions would likely to significantly frustrate implementation of
recommendations.
Name of Committee: President's Cancer Panel.
Date: December 5, 2006.
Open: December 5, 2006, 8 a.m.-4 p.m.
Agenda: Promoting Healthy Lifestyles to Reduce the Risk of
Cancer.
Place: Oregon Health & Science University Cancer Institute, 3181
Southwest Sam Jackson Park Road, Portland, OR 97239.
Closed: December 5, 2006, 4 p.m.-8 p.m.
Agenda: The Panel will discuss the Promoting Healthy Lifestyles
to Reduce the Risk of Cancer and discuss potential topics for the
2007/2008 series.
Place: Oregon Health & Science University Cancer Institute, 3181
Southwest Sam Jackson Park Road, Portland, OR 97239.
Contact Person: Abby Sandler, PhD, Executive Secretary, National
Center Institute, National Institutes of Health, Building 6116, Room
212, 6116 Executive Boulevard, Bethesda, MD 20892, 301/451-9399.
Any interested person may file written comments with the
committee by forwarding the comments to the Contact Person listed on
this notice. The comments should include the name, address,
telephone number and, when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: deainfo.nci.nih.gov/advisory/pcp/pcp.htm, where an agenda and
any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: October 17, 2006.
Linda Payne,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-8883 Filed 10-24-06; 8:45 am]
BILLING CODE 4140-01-M